Rockwell Medical (RMTI) Tops Q3 EPS by 5c, provides guidance

Rockwell Medical (NASDAQ: RMTI) reported Q3 EPS of $0.00, $0.05 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $15.9 million versus the consensus estimate of $16.18 million.

GUIDANCE:

Rockwell Medical sees FY2025 revenue of $65-70 million, versus the consensus of $68.374 million.

For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c